Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease-Reference-Cited by-同舟云学术

Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease

Published:2019-08-06 Issue:2 Volume:47 Page:270-280
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Ramusino Matteo Cotta^ORCID,Garibotto Valentina,Bacchin Ruggero,Altomare Daniele,Dodich Alessandra,Assal Frederic,Mendes Aline,Costa Alfredo,Tinazzi Michele,Morbelli Silvia D.,Bauckneht Matteo,Picco Agnese,Dottorini Massimo E.,Tranfaglia Cristina,Farotti Lucia,Salvadori Nicola,Moretti Davide,Savelli Giordano,Tarallo Anna,Nobili Flavio,Parapini Maura,Cavaliere Carlo,Salvatore Elena,Salvatore Marco,Boccardi Marina,Frisoni Giovanni B

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-019-04466-6.pdf

Reference38 articles.

1. Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14:535–62.

2. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.

3. Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease. Lancet. 2006;368:387–403.

4. Lewczuk P, Riederer P, O’Bryant SE, et al. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: an update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiatry. 2018;19:244–328.

5. Carrillo MC, Blennow K, Soares H, et al. Global standardization measurement of cerebral spinal fluid for Alzheimer’s disease: an update from the Alzheimer’s Association Global Biomarkers Consortium. Alzheimers Dement. 2013;9:137–40.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between neuropsychological assessment and amyloid status in a clinical setting.;Neuropsychology;2024-05

2. PET Imaging in Dementia: Mini-Review and Canadian Perspective for Clinical Use;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2024-03-04

3. Incremental value of amyloid PET in a tertiary memory clinic setting in China;Alzheimer's & Dementia;2024-02-08

4. CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease;International Journal of Molecular Sciences;2023-05-19

5. Cognitive Versus Hemorrhagic Onset in Cerebral Amyloid Angiopathy: Neuroimaging Features;Current Alzheimer Research;2023-04